Drug intelligence / Profile preview

Medicago sativa pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous, Intradermal
01

Overview

Medicago sativa pollen is a biologic allergenic extract derived from the pollen of the Medicago sativa plant, also known as alfalfa. It is used as a diagnostic agent to identify allergic sensitivities in patients with suspected inhalant allergies. The extract contains proteins and allergens from alfalfa pollen that, when administered through skin prick testing, provoke an IgE-mediated immune response in sensitized individuals. This localized reaction helps confirm an allergy to alfalfa pollen. It was first approved in the United States in 1965 and is manufactured by several companies as an injectable solution.

Other names
alfalfa pollen allergenic extractALFALFA POLLEN
02

Targets

pMHC (Peptide-MHC complex family)

Beyond the preview

Go deeper on Medicago sativa pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicago sativa pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call